| Typicality: | 0.363 |
| Saliency: | 0.265 |
| for initiation of antibody development | 3 | purpose |
| directly | 2 | manner |
| vaccine → be based on → dendritic cells | 6 |
| vaccine → activate → dendritic cells | 5 |
| vaccine → target → dendritic cells | 5 |
| vaccine → use → dendritic cells | 5 |
| negative | neutral | positive |
| 0.086 | 0.741 | 0.173 |
| Raw frequency | 21 |
| Normalized frequency | 0.265 |
| Modifier score | 0.500 |
| Perplexity | 60.881 |